These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8796281)

  • 21. Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents.
    Flight S; Johnson L; Trabi M; Gaffney P; Lavin M; de Jersey J; Masci P
    Pathophysiol Haemost Thromb; 2005; 34(4-5):188-93. PubMed ID: 16707925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of kallikrein cDNAs from the African rodent Mastomys.
    Fahnestock M
    DNA Cell Biol; 1994 Mar; 13(3):293-300. PubMed ID: 7909667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats.
    Chen LM; Chao L; Chao J
    Hum Gene Ther; 1997 Feb; 8(3):341-7. PubMed ID: 9048201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of hypotensive responses of captopril and enalapril by the kallikrein inhibitor aprotinin in spontaneously hypertensive rats.
    Sharma JN; Amrah SS; Noor AR
    Pharmacology; 1995 Jun; 50(6):363-9. PubMed ID: 7568335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.
    Lawrence MG; Lai J; Clements JA
    Endocr Rev; 2010 Aug; 31(4):407-46. PubMed ID: 20103546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
    Chao J; Chao L
    Pharmacol Res; 1997 Jun; 35(6):517-22. PubMed ID: 9356201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.
    Cleutjens KB; van der Korput HA; Ehren-van Eekelen CC; Sikes RA; Fasciana C; Chung LW; Trapman J
    Mol Endocrinol; 1997 Aug; 11(9):1256-65. PubMed ID: 9259317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
    Klucky B; Mueller R; Vogt I; Teurich S; Hartenstein B; Breuhahn K; Flechtenmacher C; Angel P; Hess J
    Cancer Res; 2007 Sep; 67(17):8198-206. PubMed ID: 17804733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of recombinant tissue kallikrein from Escherichia coli and yeast.
    Wang J; Chao J; Chao L
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):63-71. PubMed ID: 2039483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue kallikrein-binding protein reduces blood pressure in transgenic mice.
    Chen LM; Ma Jx; Liang YM; Chao L; Chao J
    J Biol Chem; 1996 Nov; 271(44):27590-4. PubMed ID: 8910346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats.
    Chao J; Jin L; Chen LM; Chen VC; Chao L
    Hum Gene Ther; 1996 May; 7(8):901-11. PubMed ID: 8727504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and characterization of human tissue kallikrein variants.
    Chan H; Springman EB; Clark JM
    Protein Expr Purif; 1998 Apr; 12(3):361-70. PubMed ID: 9535704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency.
    Potier L; Waeckel L; Richer C; Roussel R; Bouby N; Alhenc-Gelas F
    Biol Chem; 2013 Mar; 394(3):329-33. PubMed ID: 23324381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene.
    Tschöpe C; Walther T; Königer J; Spillmann F; Westermann D; Escher F; Pauschinger M; Pesquero JB; Bader M; Schultheiss HP; Noutsias M
    FASEB J; 2004 May; 18(7):828-35. PubMed ID: 15117887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helodermatine, a kallikrein-like, hypotensive enzyme from the venom of Heloderma horridum horridum (Mexican beaded lizard).
    Alagon A; Possani LD; Smart J; Schleuning WD
    J Exp Med; 1986 Dec; 164(6):1835-45. PubMed ID: 3537191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
    Wolf WC; Yoshida H; Agata J; Chao L; Chao J
    Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice.
    Meneton P; Bloch-Faure M; Hagege AA; Ruetten H; Huang W; Bergaya S; Ceiler D; Gehring D; Martins I; Salmon G; Boulanger CM; Nussberger J; Crozatier B; Gasc JM; Heudes D; Bruneval P; Doetschman T; Ménard J; Alhenc-Gelas F
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2634-9. PubMed ID: 11226291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
    Katz BA; Liu B; Barnes M; Springman EB
    Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions.
    Dumke CL; Kim J; Arias EB; Cartee GD
    J Appl Physiol (1985); 2002 Feb; 92(2):657-64. PubMed ID: 11796678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers.
    Clements J; Mukhtar A
    Immunopharmacology; 1997 Jun; 36(2-3):217-20. PubMed ID: 9228549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.